$0.95 EPS Expected for II-VI Incorporated (NASDAQ:IIVI) This Quarter

Wall Street analysts predict that II-VI Incorporated (NASDAQ:IIVI – Get Rating) will announce earnings of $0.95 per share for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for II-VI’s earnings. The lowest EPS estimate is $0.87 and the highest is $1.05. II-VI posted earnings of $0.88 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 8%. The firm is expected to announce its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that II-VI will report full-year earnings of $3.61 per share for the current year, with EPS estimates ranging from $3.47 to $3.79. For the next fiscal year, analysts anticipate that the business will post earnings of $4.40 per share, with EPS estimates ranging from $4.00 to $4.84. Zacks’ EPS averages are a mean average based on a survey of research analysts that that provide coverage for II-VI.

II-VI (NASDAQ:IIVI – Get Rating) last announced its earnings results on Tuesday, May 10th. The scientific and technical instruments company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.11. II-VI had a return on equity of 13.85% and a net margin of 8.44%. The company had revenue of $827.72 million for the quarter, compared to analyst estimates of $804.79 million. During the same period in the prior year, the company posted $0.80 EPS. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year.

Several brokerages recently issued reports on IIVI. Canaccord Genuity Group reduced their target price on II-VI from $104.00 to $88.00 and set a “buy” rating on the stock in a research report on Friday, February 11th. Raymond James upped their target price on II-VI from $79.00 to $82.00 in a research report on Tuesday, May 10th. B. Riley upped their target price on II-VI from $87.00 to $88.00 and gave the company a “buy” rating in a research report on Thursday, February 10th. Zacks Investment Research lowered II-VI from a “hold” rating to a “sell” rating in a research report on Friday, May 13th. Finally, Craig Hallum dropped their price target on II-VI from $100.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, April 14th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, II-VI has a consensus rating of “Hold” and a consensus price target of $81.08.

In other news, CTO Christopher Koeppen sold 500 shares of the business’s stock in a transaction that occurred on Monday, April 18th. The stock was sold at an average price of $61.71, for a total value of $30,855.00. Following the completion of the sale, the chief technology officer now directly owns 29,329 shares in the company, valued at $1,809,892.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Vincent D. Mattera, Jr. sold 2,000 shares of the stock in a transaction that occurred on Friday, March 18th. The shares were sold at an average price of $70.00, for a total value of $140,000.00. The disclosure for this sale can be found here. Insiders sold 10,479 shares of company stock worth $757,857 in the last 90 days. Company insiders own 2.50% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Lindbrook Capital LLC acquired a new stake in II-VI in the 4th quarter valued at $140,000. Hunter Associates Investment Management LLC grew its stake in II-VI by 160.0% in the 4th quarter. Hunter Associates Investment Management LLC now owns 32,500 shares of the scientific and technical instruments company’s stock valued at $2,221,000 after acquiring an additional 20,000 shares during the period. United Capital Financial Advisers LLC grew its stake in II-VI by 3,861.5% in the 3rd quarter. United Capital Financial Advisers LLC now owns 172,246 shares of the scientific and technical instruments company’s stock valued at $10,225,000 after acquiring an additional 167,898 shares during the period. IFP Advisors Inc grew its stake in II-VI by 17.4% in the 4th quarter. IFP Advisors Inc now owns 2,934 shares of the scientific and technical instruments company’s stock valued at $201,000 after acquiring an additional 434 shares during the period. Finally, Alpha Paradigm Partners LLC acquired a new stake in II-VI in the 4th quarter valued at $639,000. 97.88% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:IIVI opened at $65.09 on Wednesday. The business’s 50-day moving average is $65.81 and its 200 day moving average is $66.31. II-VI has a 1 year low of $54.35 and a 1 year high of $75.23. The firm has a market capitalization of $6.93 billion, a P/E ratio of 35.96, a P/E/G ratio of 1.42 and a beta of 1.47. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.99 and a quick ratio of 1.58.

II-VI Company Profile (Get Rating)

II-VI Incorporated develops, manufactures, and markets engineered materials, optoelectronic components, and devices worldwide. It operates through two segments, Compound Semiconductors and Photonic Solutions. The Compound Semiconductors segment provides optical and electro-optical components and materials used in high-power CO2 lasers, fiber-lasers, and direct diode lasers for materials processing applications; infrared optical components and high-precision optical assemblies for aerospace and defense, medical, and commercial laser imaging applications; semiconductor lasers and detectors for optical interconnects and sensing applications; engineered materials for thermoelectric, ceramics, and silicon carbide various applications; and compound semiconductor epitaxial wafers for applications in optical and wireless communication.

Recommended Stories